经尿道膀胱肿瘤电切术治疗肌层浸润性膀胱癌的临床疗效

doi:10.6040/j.issn.1671-7554.0.2018.288

摘要/Abstract

摘要： 目的探讨经尿道膀胱肿瘤电切术治疗T2期肌层浸润性膀胱癌的临床疗效及安全性。方法回顾性分析101例肌层浸润性膀胱癌患者,所有患者术后病理均为浸润性尿路上皮癌(T2期),观察组84例行经尿道膀胱肿瘤电切术,将肿瘤位置膀胱壁全部切除,包括周围1.5 cm膀胱黏膜组织。对照组17例行根治性膀胱切除术,观察记录两组患者复发情况、并发症、生存率及生活质量等临床资料。结果观察组平均手术时间(53.1±10.3)min低于对照组的(202.4±31.5)min,观察组平均住院时间(11.7±1.7)d低于对照组的(28.0±4.7)d,观察组平均术中出血量(13.7±6.3)mL少于对照组的(470.6±143.1)mL,差异均有统计学意义(P<0.001)。观察组和对照组1、3、5年生存率分别为97.6%、84.5%、78.5%和94.1%、82.4%、76.4%,组间比较差异均无统计学意义(P>0.05)。观察组4例患者术后出现尿路感染,经抗炎对症治疗后痊愈。对照组1例患者出现肾积水行肾穿刺造瘘引流,1例患者出现输尿管梗阻,2例出现尿路感染行抗炎治疗,1例患者出现急性肠梗阻行手术治疗。观察组较对照组并发症发生率及住院费用低,保留膀胱,生活质量明显提高,患者满意度高。结论经尿道膀胱肿瘤电切术对于肿瘤单发、体积较小(直径≤2 cm)、分期较早(T2期)的肌层浸润性膀胱癌疗效可靠,安全性及术后生活质量高。对于肿瘤多发、体积较大(直径>2 cm)的肌层浸润性膀胱癌应首选根治性膀胱切除术。

关键词: 经尿道膀胱肿瘤电切术, 根治性膀胱切除术, 肌层浸润性膀胱癌, 生存率

Abstract: Objective To investigate the clinical efficacy and safety of transurethral resection of bladder tumor(TURBT)for T2 stage muscle invasive bladder cancer(MIBC). Methods The clinical data of 101 MIBC cases treated during Jan. 2008 and Feb. 2013 were retrospectively analyzed. All tumors were pathologically T2 stage. The patients were divided into the observation group(n=84)and control group(n=17). Patients in the observation received TURBT, during which the bladder wall around the tumor was removed thoroughly, including 1.5 cm bladder mucosa. Patients in the control group underwent radical cystectomy and pelvic lymph node dissection. The recurrence, complications, survival rate and quality of life of the two groups were recorded and compared. Results The average operation time was shorter in the observation group than in the control group［(53.1±10.3)min vs(202.4±31.5)min］. The average hospitalization time was shorter in the observation group than in the control group ［(11.7±1.7)d vs(28.0±4.7)d ］. 山东大学学报 (医学版)56卷7期 -刘杰,等.经尿道膀胱肿瘤电切术治疗肌层浸润性膀胱癌的临床疗效 \=- The average intraoperative blood loss was less in the observation group than in the control group［(13.7±6.3)mL vs(470.6±143.1)mL］. The differences were statistically significant(P<0.001). The 1-year, 3-year and 5-year survival rate were 97.6%, 84.5%, and 78.5% in the observation group, and were 94.1%, 82.4% and 76.4% in the control group, with no statistical differences(P>0.05). In the observation group, urinary tract infection occurred in 4 cases, who were cured after anti-infection treatment. In the control group, hydronephrosis, ureteral obstruction and acute intestinal obstruction occurred in 1 case respectively. The complication rate and hospitalization costs were lower in the observation group than in the control group. In the observation group, the bladders were preserved, and the quality of life was significantly improved. Conclusion For patients with T2 stage, sporadic, small size(diameter ≤2 cm)MIBC, TURBT is safe and effective, and can improve patients’ quality of life. For patients with multiple, large size(diameter >2 cm)MIBC, radical cystectomy is the first choice.

Key words: Transurethral resection of bladder tumor, Radical cystectomy, Muscle-invasive bladder cancer, Survival rate

中图分类号:

R737.14

刘杰, 崔伟,车梓,崔志强,王策正,王彤,李明,刘玲,杨全成,孙彬,高佃军,聂清生. 经尿道膀胱肿瘤电切术治疗肌层浸润性膀胱癌的临床疗效[J]. 山东大学学报 (医学版), 2018, 56(7): 81-85.

LIU Jie, CUI Wei, CHE Zi, CUI Zhiqiang, WANG Cezheng, WANG Tong, LI Ming, LIU Ling, YANG Quancheng, SUN Bin, GAO Dianjun, Nie Qingsheng. Efficacy of transurethral resection of bladder tumor in the treatment of muscle-invasive bladder cancer[J]. Journal of Shandong University (Health Sciences), 2018, 56(7): 81-85.

参考文献

[1] Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017[J]. CA Cancer J Clin, 2017, 67(1): 7-30.
[2] Satyanarayana R, Kallingal G, Parekh D. Current status of robotic and laparoscopic techniques in radical cystectomy and diversion procedures for bladder cancer review[J] Minerva Urol Nefrol, 2014, 66(1): 1-14.
[3] Khosravi-Shahi P, Cabezón-Gutiérrez L. Selective organ reservation in muscle-invasive bladder cancer: review of the literature[J]. Surg Oncol, 2012, 21(1): e17-22.
[4] 李军, 李伟, 刘敏, 等. 经尿道前列腺等离子电切术中失血量的相关因素分析[J]. 同济大学学报(医学版), 2014, 35(4): 50-53. LI Jun, LI Wei, LIU Min, et al. Factors affecting hemorrhage during transurethral plasma kinetic resection of prostate[J]. Journal of Tongji University(Medical Science), 2014, 35(4): 50-53.
[5] 那彦群. 中国泌尿外科疾病诊断治疗指南[M]. 北京: 人民卫生出版社, 2014: 20-60.
[6] Milowsky MI, Rumble RB, Booth CM, et al. Guideline on muscle-invasive and metastatic bladder cancer(European Association of Urology Guideline): American society of clinical oncology clinical practice guideline endorsement[J]. J Clin Oncol, 2016, 34(16): 1945-1952.
[7] de Nunzio C, Cindolo L, Leonardo C, et al. Analysis of radical cystectomy and urinary diversion complications with the Clavien classification system in an Italian real life cohort[J]. Eur J Surg Oncol, 2013, 39(7): 792-798.
[8] Gakis G, Efstathiou J, Lerner SP, et al. ICUD-EAU International consultation on bladder cancer 2012: radical cystectomy and b1adder preservation for muscle-invasive urothelial carcinoma of the bladder[J]. Eur Urol, 2013, 63(1): 45-57.
[9] Hautmann RE, de Petriconi RC, Pfiffer C, et al. Radical cystectomy for urothelial carcinoma of the bladder without neoadjuvant or adjuvant therapy: long-term results in 1100 patients.[J]. Eur Urol, 2012, 61(5): 1039-1047.
[10] Yoo S, You D, Jeong IG, et al. Does radical cystectomy improve overall survival in octogenarians with muscle-invasive bladder cancer?[J]. Korean J Urol, 2011, 52(7): 446-451.
[11] Takeshita H, Kihara K, Masuda H, et al. Bladder sparing therapy in muscle-invasive bladder cancer by induction chemoradiotherapy plus partial cystectomy with pelvic lymph node dissection: assessments of quality of life and urinary functions[J]. J Urol, 2014, 191(4): e555- e555.
[12] 高宏, 刘岩, 王泽新, 等. 经尿道电切联合围术期膀胱热灌注治疗老年膀胱癌的疗效[J]. 中国老年学杂志, 2012, 32(8): 1603-1604.
[13] 周晓峰, 丁振山, 方丹波, 等. 经尿道保留膀胱的不同手术方法对老年肌层浸润性膀胱癌的疗效分析[J]. 中华医学杂志, 2016, 96(16): 1278-1280. ZHOU Xiaofeng, DING Zhenshan, FANG Danbo, et al. Selective bladder preservation in muscle-invasive bladder cancer by transurethral resection combined with intravesical instillation therapy: analysis of clinical effect in the elderly[J]. Med J China, 2016, 96(16): 1278-1280.
[14] Herr HW. Transurethral resection of muscle-invasive bladder cancer: 10-year outcome[J]. J Clin Oncol, 2001, 19(1): 89-93.
[15] Solsona E, Iborra I, Collado A, et al. Feasibility of radical transurethral resection as monotherapy for selected patients with muscle invasive bladder cancer[J]. J Urol, 2010, 184(2): 475-480.
[16] Culp SH, Dickstein RJ, Grossman HB, et al. Refining patient selection for neoadjuvant chemotherapy before radical cystectomy[J]. J Urol, 2014, 191(1): 40-47.
[17] Smith ZL, Christodouleas JP, Keefe SM, et al. Bladder preservation in the treatment of muscle-invasive bladder cancer(MIBC): a review of the literature and a practical approach to therapy[J]. BJU Int, 2013, 112(1): 13-25.
[18] Hara T, Nishijima J, Miyachika Y, et al. Primary cT2 bladder cancer: a good candidate for radiotherapy combined with cisplatin for bladder preservation[J]. JPN J Clin Oncol, 2011, 41(7): 902-907.
[19] Miyamoto DT, Drumm MR, Clayman RH, et al. Outcomes and tolerability of selective bladder preservation by combined modality therapy for invasive bladder cancer in elderly patients[J]. Int J Radiat Oncol, Biol, Phys, 2017, 99(2):S120. doi: 10.1016/j.ijrobp.2017.06.282.
[20] Weiss C, Engehausen DG, Krause FS, et al. Radiochemotherapy with cisplatin and 5-fluorouracil after transurethral surgery in patients with bladder cancer[J]. Int J Radiat Oncol, Biol Phys, 2007, 68(4): 1072-1080.
[21] 赵阳, 陈贵平, 王华, 等. 膀胱部分切除术在局限性肌层浸润性膀胱癌治疗中的作用[J]. 中华泌尿外科杂志, 2013, 34(7): 497-500. ZHAO Yang, CHEN Guiping, WANG Hua, et al. Partial cystectomy in treatment of localized muscle invasive bladder cancer[J]. Chin J Urol, 2013, 34(7): 497-500.
[22] 褚雷, 李青, 李博, 等. 影响T2期膀胱移行细胞癌患者预后因素分析[J]. 山东大学学报(医学版), 2008, 46(3): 284-287. CHU Lei, LI Qing, LI Bo, et al. Parameters influencing the long-term survival of patients with T2 stage transitional cell carcinoma of the bladder[J]. Journal of Shandong University(Health Sciences), 2008, 46(3): 284-287.
[23] Krause FS, Walter B, Ott OJ, et al. 15-year survival rates after transurethral resection and radiochemotherapy or radiation in bladder cancer treatment[J]. Anticancer Res, 2011, 31(3): 985-990.
[24] 李炫昊, 杜林栋. 保留膀胱的综合治疗在浸润性膀胱癌中的应用现状[J/CD]. 中华临床医师杂志, 2013, 7(3): 920-923.
[25] Griebling TL. Re: Comparison of radical cystectomy with conservative treatment in geriatric(≥80)patients with muscle-invasive bladder cancer[J]. J Urol, 2014, 192(2): 372. doi: 10.1016/j.juro.2014.05.058.
[26] Zapatero A, Martin De Vidales C, Arellano R, et al. Long term results of two prospective bladder-sparing trimodality approaches for invasive bladder cancer: neoadjuvant chemotherapy and concurrent radio-chemotherapy[J]. Urology, 2012, 80(5): 1056-1062.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed